Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
McKesson
Colorcon
Boehringer Ingelheim
AstraZeneca

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Torsemide - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for torsemide and what is the scope of freedom to operate?

Torsemide is the generic ingredient in two branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Mylan Speciality Lp, Apotex Inc, Aurobindo Pharma, Hetero Labs Ltd Iii, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for torsemide. Fifteen suppliers are listed for this compound.

Drug Prices for torsemide

See drug prices for torsemide

Drug Sales Revenue Trends for torsemide

See drug sales revenues for torsemide

Recent Clinical Trials for torsemide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 4
Duke UniversityPhase 4
New York City Health and Hospitals CorporationN/A

See all torsemide clinical trials

Pharmacology for torsemide
Synonyms for torsemide
1-[[4-(3-methylanilino)-3-pyridinyl]sulfonyl]-3-propan-2-ylurea
1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea
1-[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl-3-propan-2-yl-urea
1-{4-[(3-methylphenyl)amino]pyridine-3-sulfonyl}-3-(propan-2-yl)urea
1-isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea
1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea
1-isopropyl-3-[(4- m -toluidino-3-pyridyl) sulfonyl]urea
1-isopropyl-3-[[4-(3-methylanilino)-3-pyridyl]sulfonyl]urea
1189375-06-1
211T406
3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
3-Pyridinesulfonamide, N-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-
3-pyridinesulfonamide,N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-
4-[(3-methylphenyl)amino]-N-(propan-2-ylcarbamoyl)pyridine-3-sulfonamide
56211-40-6
A830961
AB0006854
AB00514011
AB00514011_10
AB00514011_11
AB00514011-09
AB2000227
AC 4464
AC-18762
AC-4464
AC1L26H7
AC1Q6UVM
AC4464
ACM1189375061
AKOS015894937
ALBB-027267
AN-919
ANW-41652
API0004454
BCP07286
BDBM64107
BG0484
BIDD:GT0623
BM 02015
BM-02015
BM02.015
BPBio1_001341
BRD-K30480208-001-05-2
BRN 0498515
BSPBio_001219
BSPBio_003503
C-20564
CAS-56211-40-6
CC-35108
CCG-40257
CCRIS 6736
CHEBI:9637
CHEMBL1148
cid_41781
CPD000466313
CS-2227
CT0260
CTK8B3035
D00382
DB00214
Demadex
Demadex (TN)
Dilutol
DSSTox_CID_3690
DSSTox_GSID_23690
DSSTox_RID_77149
DTXSID2023690
FT-0630689
GJ-1090
GTPL7312
HMS1571M21
HMS1922N05
HMS2051L21
HMS2098M21
HMS2234N14
HMS3373G20
HMS3393L21
HMS3715M21
HY-B0247
I06-0056
JDL 464
JDL-464
KBio2_002256
KBio2_004824
KBio2_007392
KBio3_003008
KBioGR_000820
KBioSS_002257
KS-1123
LS-131973
Luprac
Luprac (TN)
MCULE-2734924315
MFCD00866166
MLS000759418
MLS001165687
MLS001195611
MLS001424121
MLS006010744
MolPort-002-885-870
N-(((1-Methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-3-pyridinesulfonamide
N-({4-[(3-methylphenyl)imino]-1,4-dihydropyridin-3-yl}sulfonyl)propane-2-carbamimidic acid
N-(Isopropylcarbamoyl)-4-(m-tolylamino)pyridine-3-sulfonamide
N-(isopropylcarbamoyl)-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
N-[(propan-2-yl)carbamoyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
n-[[(1-methylethyl)amino]carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide
N-{[(1-methylethyl)amino]carbonyl}-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide
NC00238
NCGC00016879-01
NCGC00016879-02
NCGC00016879-03
NCGC00016879-04
NCGC00016879-06
NCGC00016879-07
NCGC00095141-01
NCGC00095141-02
NCGC00095141-03
NGBFQHCMQULJNZ-UHFFFAOYSA-N
Presoril
Prestwick0_001030
Prestwick1_001030
Prestwick2_001030
Prestwick3_001030
PubChem18545
PW-2132
Q-201846
R3923
s1698
SAM001246567
SC-13773
SCHEMBL41184
SMR000466313
SPBio_001063
SPBio_003080
Spectrum_001776
SPECTRUM1505211
Spectrum2_001142
Spectrum3_001832
Spectrum4_000290
Spectrum5_001699
SR-01000759362
SR-01000759362-5
STL388026
Sutril
TL8003646
Toradiur
Torasemida
Torasemida [INN-Spanish]
Torasemide
Torasemide (JAN/INN)
Torasemide [INN]
Torasemide anhydrous, European Pharmacopoeia (EP) Reference Standard
Torasemide for system suitability, European Pharmacopoeia (EP) Reference Standard
Torasemide N
Torasemide, Anhydrous
Torasemidum
Torasemidum [INN-Latin]
Torem
Torocard
Torrem
Torsemide (Demadex)
Torsemide (USP)
Torsemide [USAN:USP]
Torsemide [USAN]
Torsemide, >=98% (HPLC), solid
Torsemide, United States Pharmacopeia (USP) Reference Standard
Tox21_110662
Tox21_110662_1
TR-019752
Unat
UNII-W31X2H97FB
VA11897
W31X2H97FB
ZINC5823
ZX-AN025776
Paragraph IV (Patent) Challenges for TORSEMIDE
Tradename Dosage Ingredient NDA Submissiondate
DEMADEX TABLET;ORAL torsemide 020136

US Patents and Regulatory Information for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii TORSEMIDE torsemide TABLET;ORAL 079234-002 Jan 27, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int TORSEMIDE torsemide TABLET;ORAL 076943-003 Mar 1, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Pliva Pharm Ind TORSEMIDE torsemide TABLET;ORAL 076346-004 Oct 19, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds TORSEMIDE torsemide TABLET;ORAL 078478-003 Feb 26, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms TORSEMIDE torsemide TABLET;ORAL 090613-002 Mar 22, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for torsemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-003 Aug 23, 1993   Start Trial   Start Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993   Start Trial   Start Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993   Start Trial   Start Trial
Roche DEMADEX torsemide INJECTABLE;INJECTION 020137-002 Aug 23, 1993   Start Trial   Start Trial
Mylan Speciality Lp DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Baxter
Merck
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.